Atlas Venture Life Science Advisors, LLC Day One Biopharmaceuticals, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $799 Million
- Q1 2024
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 6,430,257 shares of DAWN stock, worth $85.3 Million. This represents 13.29% of its overall portfolio holdings.
Number of Shares
6,430,257
Previous 7,608,394
15.48%
Holding current value
$85.3 Million
Previous $111 Million
4.37%
% of portfolio
13.29%
Previous 17.46%
Shares
6 transactions
Others Institutions Holding DAWN
# of Institutions
148Shares Held
60MCall Options Held
47.7KPut Options Held
61.3K-
Black Rock Inc. New York, NY5.03MShares$66.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$63.4 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.81MShares$50.5 Million0.02% of portfolio
-
State Street Corp Boston, MA2.89MShares$38.4 Million0.0% of portfolio
-
Viking Global Investors LP2.56MShares$34 Million0.16% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $975M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...